{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:02:58Z","timestamp":1751515378373,"version":"3.41.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Antibodies are important for protection against malaria. For optimal protective activity, it is thought that antibodies need to have high affinity. A longitudinal study conducted in Uganda followed newborn infants and their mothers for nine months. The study found that antibody affinity (here measured as dissociation rate constant, k<jats:sub>d<\/jats:sub>) against the merozoite antigens AMA1 and MSP2 decreased from birth to six months in the infants, then gradually increased to 9 months, but not reaching the level observed in the mothers. In contrast, affinity against the sporozoite antigen CSP, did not change throughout the study period. Among mothers, no significant changes in antibody affinity were observed for any antigen, which is consistent with expectations for adults in an endemic area. Comparing specific antibody affinities to total antibody levels revealed almost no correlations, indicating that antibody magnitude and affinity evolve differently during immune development. Significant correlations were observed between antibody affinities and some atypical memory B cells. In conclusion, our study shows that development of naturally acquired slowly dissociating (high affinity) antibodies against malaria can evolve separately across different antigens. This is important information for future vaccine development studies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1562671","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:53:12Z","timestamp":1751435592000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of high affinity antibodies to Plasmodium falciparum merozoite and sporozoite antigens during infancy and adulthood"],"prefix":"10.3389","volume":"16","author":[{"given":"Allan","family":"Lugaajju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Idro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Kiwuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien R.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne E.","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Linse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina E. M.","family":"Persson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","article-title":"World Malaria Report 2024","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-3024.2006.00808.x","article-title":"Immune effector mechanisms in malaria","volume":"28","author":"Marsh","year":"2006","journal-title":"Parasite Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.918","article-title":"Contribution of humoral immunity to the therapeutic response in falciparum malaria","volume":"65","author":"Mayxay","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/PL00006215","article-title":"Sequence diversity and molecular evolution of the merozoite surface antigen 2 of Plasmodium falciparum","volume":"45","author":"Felger","year":"1997","journal-title":"J Mol Evol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2006.03.011","article-title":"Origins of sequence diversity in the malaria vaccine candidate merozoite surface protein-2 (MSP-2) in Amazonian isolates of Plasmodium falciparum","volume":"376","author":"Hoffmann","year":"2006","journal-title":"Gene"},{"key":"B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.exppara.2006.05.003","article-title":"Plasmodium falciparum: worldwide sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-2 (MSP-2)","volume":"115","author":"Ferreira","year":"2007","journal-title":"Exp Parasitol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2009.27","article-title":"The future for blood-stage vaccines against malaria","volume":"87","author":"Richards","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1475-2875-10-182","article-title":"Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT and Montanide ISA 51 in rhesus macaques","volume":"10","author":"Kusi","year":"2011","journal-title":"Malar J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051023","article-title":"Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria","volume":"7","author":"Drew","year":"2012","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00665-12","article-title":"Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2","volume":"80","author":"Adda","year":"2012","journal-title":"Infect Immun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00866-13","article-title":"Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum","volume":"82","author":"Boyle","year":"2014","journal-title":"Infect Immun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni.f.205","article-title":"Immunity to malaria: more questions than answers","volume":"9","author":"Langhorne","year":"2008","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00025-08","article-title":"Acquired immunity to malaria","volume":"22","author":"Doolan","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria","volume":"42","author":"Boyle","year":"2015","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/infdis\/jiy170","article-title":"Human immunization with a polymorphic malaria vaccine candidate induced antibodies to conserved epitopes that promote functional antibodies to multiple parasite strains","volume":"218","author":"Feng","year":"2018","journal-title":"J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0166-6851(94)90096-5","article-title":"Differential localization of full-length and processed forms of PF83\/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites","volume":"67","author":"Narum","year":"1994","journal-title":"Mol Biochem Parasitol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311331200","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-011-1258-4","article-title":"O-GlcNAc modification of the anti-malarial vaccine candidate PfAMA1: in silico-defined structural changes and potential to generate a better vaccine","volume":"39","author":"Uddin","year":"2012","journal-title":"Mol Biol Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv154","article-title":"Proteolytic cleavage of the plasmodium falciparum circumsporozoite protein is a target of protective antibodies","volume":"212","author":"Espinosa","year":"2015","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006465","article-title":"Evaluation of RTS,S\/AS02A and RTS,S\/AS01B in adults in a high malaria transmission area","volume":"4","author":"Polhemus","year":"2009","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.059","article-title":"Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)","volume":"37","author":"Cawlfield","year":"2019","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202163011","article-title":"Circumsporozoite Surface Protein-based malaria vaccines: a review","volume":"63","author":"Almeida","year":"2021","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0209-5","article-title":"Antibodies against Plasmodium falciparum malaria at the molecular level","volume":"19","author":"Julien","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41467-019-10195-z","article-title":"Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S\/AS01E malaria vaccine efficacy","volume":"10","author":"Dobano","year":"2019","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.1.9677","article-title":"From the circumsporozoite protein to the RTS, S\/AS candidate vaccine","volume":"6","author":"Cohen","year":"2010","journal-title":"Hum Vaccin"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.5.1834-1839.1992","article-title":"Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A","volume":"60","author":"Fries","year":"1992","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12916-018-1054-2","article-title":"Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children","volume":"16","author":"Kurtovic","year":"2018","journal-title":"BMC Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-021-21998-4","article-title":"Mechanisms and targets of Fc\u03b3-receptor mediated immunity to malaria sporozoites","volume":"12","author":"Feng","year":"2021","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-090817-062427","article-title":"The promise of a malaria vaccine-are we closer","volume":"72","author":"Laurens","year":"2018","journal-title":"Annu Rev Microbiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007590","article-title":"The quantity and quality of African children\u2019s IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria","volume":"4","author":"Courtin","year":"2009","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001155","article-title":"Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics","volume":"185","author":"Good-Jacobson","year":"2010","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9026","DOI":"10.1038\/s41598-018-27361-w","article-title":"Factors influencing the induction of high affinity antibodies to Plasmodium falciparum merozoite antigens and how affinity changes over time","volume":"8","author":"Tijani","year":"2018","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1475-2875-7-186","article-title":"Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria","volume":"7","author":"Leoratti","year":"2008","journal-title":"Malar J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040049","article-title":"High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria","volume":"7","author":"Tutterrow","year":"2012","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-3024.2009.01193.x","article-title":"Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection","volume":"32","author":"Akpogheneta","year":"2010","journal-title":"Parasite Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052939","article-title":"Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya","volume":"7","author":"Ibison","year":"2012","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115126","article-title":"Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S\/AS01E in young children","volume":"9","author":"Olotu","year":"2014","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200061","article-title":"A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity","volume":"217","author":"Thai","year":"2020","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032242","article-title":"High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria","volume":"7","author":"Reddy","year":"2012","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.52","article-title":"Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends","volume":"9","author":"Hearty","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12936-017-1697-z","article-title":"Development of Plasmodium falciparum specific naive, atypical, memory and plasma B cells during infancy and in adults in an endemic area","volume":"16","author":"Lugaajju","year":"2017","journal-title":"Malar J"},{"key":"B48","volume-title":"Uganda Malaria Indicator Survey 2014-15","year":"2015"},{"key":"B49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00018-023-04712-z","article-title":"Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines","volume":"80","author":"Drew","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00130-7","article-title":"Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of\u00a0phase 2\u00a0trial","volume":"5","author":"Kurtovic","year":"2024","journal-title":"Lancet Microbe"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2320898121","article-title":"Geospatial joint modeling of vector and parasite serology to microstratify malaria transmission","volume":"121","author":"Kearney","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021914","article-title":"A pilot randomised trial of induced blood-stage plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs","volume":"6","author":"McCarthy","year":"2011","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae259","article-title":"Declining antibody affinity over time after human vaccination with a plasmodium falciparum merozoite vaccine candidate","volume":"230","author":"Persson","year":"2024","journal-title":"J Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12866-021-02368-y","article-title":"Osteopontin and malaria: no direct effect on parasite growth, but correlation with P. falciparum-specific B cells and BAFF in a malaria endemic area","volume":"21","author":"Mortazavi","year":"2021","journal-title":"BMC Microbiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12866-015-0461-1","article-title":"Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens","volume":"15","author":"Reddy","year":"2015","journal-title":"BMC Microbiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"39462","DOI":"10.1038\/srep39462","article-title":"Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1","volume":"6","author":"Maskus","year":"2016","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.8.3310-3317.1996","article-title":"Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes","volume":"64","author":"Crewther","year":"1996","journal-title":"Infect Immun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.1.422-430.2005","article-title":"Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1","volume":"73","author":"Cortes","year":"2005","journal-title":"Infect Immun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1086\/339342","article-title":"A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea","volume":"185","author":"Genton","year":"2002","journal-title":"J Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024413","article-title":"A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide(R) ISA 720","volume":"6","author":"McCarthy","year":"2011","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(95)00076-Q","article-title":"A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life","volume":"59","author":"Achidi","year":"1995","journal-title":"Acta Trop"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1980.29.151","article-title":"Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador","volume":"29","author":"Campbell","year":"1980","journal-title":"Am J Trop Med Hyg"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1980.29.720","article-title":"The serological response to primary malaria infection in urban Ghanaian infants","volume":"29","author":"Biggar","year":"1980","journal-title":"Am J Trop Med Hyg"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.4.1047","article-title":"Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design","volume":"172","author":"Beadle","year":"1995","journal-title":"J Infect Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4489","article-title":"IgM in human immunity to Plasmodium falciparum malaria","volume":"5","author":"Boyle","year":"2019","journal-title":"Sci Adv"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1998.tb00972.x","article-title":"Placental transfer favours high avidity IgG antibodies","volume":"87","author":"Avanzini","year":"1998","journal-title":"Acta Paediatr"},{"key":"B70","doi-asserted-by":"publisher","first-page":"105179","DOI":"10.1016\/j.ebiom.2024.105179","article-title":"HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy","volume":"104","author":"Taton","year":"2024","journal-title":"EBioMedicine"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040320","article-title":"Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3","volume":"4","author":"Roussilhon","year":"2007","journal-title":"PLoS Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01129-08","article-title":"Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness","volume":"77","author":"Stanisic","year":"2009","journal-title":"Infect Immun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of igG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1741-7015-12-108","article-title":"Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria","volume":"12","author":"Osier","year":"2014","journal-title":"BMC Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1128\/IAI.01108-12","article-title":"Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I.C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice","volume":"81","author":"Kastenmuller","year":"2013","journal-title":"Infect Immun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.097","article-title":"The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity","volume":"27","author":"Bongfen","year":"2009","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0881-9","article-title":"Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs","volume":"26","author":"Murugan","year":"2020","journal-title":"Nat Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.754796","article-title":"Force spectroscopy of the plasmodium falciparum vaccine candidate circumsporozoite protein suggests a mechanically pliable repeat region","volume":"292","author":"Patra","year":"2017","journal-title":"J Biol Chem"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715812114","article-title":"Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein","volume":"114","author":"Oyen","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.775659","article-title":"Antibody targets and properties for complement-fixation against the circumsporozoite protein in malaria immunity","volume":"12","author":"Kurtovic","year":"2021","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young african children","volume":"374","author":"Olotu","year":"2016","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12936-021-03961-2","article-title":"Seven-year kinetics of RTS, S\/AS01-induced anti-CSP antibodies in young Kenyan children","volume":"20","author":"Mugo","year":"2021","journal-title":"Malar J"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aap8029","article-title":"Clonal selection drives protective memory B cell responses in controlled human malaria infection","volume":"3","author":"Murugan","year":"2018","journal-title":"Sci Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2024","article-title":"The role of antibody concentration and avidity in antiviral protection","volume":"276","author":"Bachmann","year":"1997","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00151-2","article-title":"Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants","volume":"20","author":"Longworth","year":"2002","journal-title":"Vaccine"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20121970","article-title":"Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies","volume":"210","author":"Muellenbeck","year":"2013","journal-title":"J Exp Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901297","article-title":"Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area","volume":"183","author":"Weiss","year":"2009","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015983","article-title":"A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali","volume":"6","author":"Weiss","year":"2011","journal-title":"PLoS One"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067230","article-title":"Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection","volume":"8","author":"Ayieko","year":"2013","journal-title":"PLoS One"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg8384","article-title":"Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity","volume":"7","author":"Holla","year":"2021","journal-title":"Sci Adv"},{"key":"B93","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12936-016-1190-0","article-title":"B cell sub-types following acute malaria and associations with clinical immunity","volume":"15","author":"Sullivan","year":"2016","journal-title":"Malar J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1562671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:53:13Z","timestamp":1751435593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1562671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":93,"alternative-id":["10.3389\/fimmu.2025.1562671"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1562671","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}